These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27869662)

  • 1. The Cell Killing Mechanisms of Hydroxyurea.
    Singh A; Xu YJ
    Genes (Basel); 2016 Nov; 7(11):. PubMed ID: 27869662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea Induces Cytokinesis Arrest in Cells Expressing a Mutated Sterol-14α-Demethylase in the Ergosterol Biosynthesis Pathway.
    Xu YJ; Singh A; Alter GM
    Genetics; 2016 Nov; 204(3):959-973. PubMed ID: 27585850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea-The Good, the Bad and the Ugly.
    Musiałek MW; Rybaczek D
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the use of hydroxyurea as an anti-human immunodeficiency virus drug.
    Lori F; Lisziewicz J
    Clin Infect Dis; 2000 Jun; 30 Suppl 2():S193-7. PubMed ID: 10860905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK; McClarty GA; Chan AK; Thelander L; Wright JA
    Cancer Res; 1988 Apr; 48(8):2029-35. PubMed ID: 2832057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxyribonucleotide metabolism and cyclic AMP resistance in hydroxyurea-resistant S49 T-lymphoma cells.
    Albert DA; Gudas LJ; Nodzenski E
    J Cell Physiol; 1987 Feb; 130(2):262-9. PubMed ID: 3029148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
    McClarty GA; Chan AK; Wright JA
    Cancer Res; 1986 Sep; 46(9):4516-21. PubMed ID: 2425956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the mutagenic activity of hydroxyurea on the G1-S-G2 phases of the cell cycle: an in vitro study.
    de Lima PD; Cardoso PC; Khayat AS; Bahia Mde O; Burbano RR
    Genet Mol Res; 2003 Sep; 2(3):328-33. PubMed ID: 14966681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea may enhance effectiveness of anti-HIV regimens presently in use.
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(2):1-2. PubMed ID: 11365124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SOD1 and LYS7 sensitizes Saccharomyces cerevisiae to hydroxyurea and DNA damage agents and downregulates MEC1 pathway effectors.
    Carter CD; Kitchen LE; Au WC; Babic CM; Basrai MA
    Mol Cell Biol; 2005 Dec; 25(23):10273-85. PubMed ID: 16287844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic killing of HeLa cells by hydroxyurea and caffeine.
    Beetham KL; Busse PM; Tolmach LJ
    J Cell Physiol; 1983 Jun; 115(3):283-90. PubMed ID: 6853607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M2 subunit of ribonucleotide reductase is a target of cyclic AMP-dependent protein kinase.
    Albert DA; Nodzenski E
    J Cell Physiol; 1989 Jan; 138(1):129-36. PubMed ID: 2536034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antiviral action of ribonucleotide reductase inhibitors and 3'-azido-3'-deoxythymidine on HIV type 1 infection in vitro.
    Giacca M; Borella S; Calderazzo F; Bianchi LC; D'Agaro P; Rampazzo C; Bianchi V; Reichard P
    AIDS Res Hum Retroviruses; 1996 May; 12(8):677-82. PubMed ID: 8744578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.
    Lewis WH; Wright JA
    J Cell Physiol; 1978 Oct; 97(1):87-97. PubMed ID: 568630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-phase checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex.
    Katou Y; Kanoh Y; Bando M; Noguchi H; Tanaka H; Ashikari T; Sugimoto K; Shirahige K
    Nature; 2003 Aug; 424(6952):1078-83. PubMed ID: 12944972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea.
    Bowers M
    BETA; 1997 Mar; ():9-11. PubMed ID: 11364534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
    Carter GL; Cory JG
    Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients.
    Rodríguez A; Kouegnigan L; Ferster A; Cotton F; Duez P
    Hemoglobin; 2012; 36(6):545-54. PubMed ID: 23094637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.